Hypersensitivity Clinical Trial
Official title:
Incidence of Perioperative Hypersensitivity Reactions to Propofol in Children Allergic to Egg and/or Soy
NCT number | NCT04839666 |
Other study ID # | 2021- |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | January 1, 2010 |
Est. completion date | August 31, 2016 |
Verified date | May 2023 |
Source | Universitair Ziekenhuis Brussel |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The investigators would only include the children who received propofol (Propolipid, Fresenius Kabi, Schelle, Belgium) for sedation, the investigators would exclude the children that didn't receive propofol during the procedure. The investigators would analyze the incidence of hypersensitivity reaction to propofol in children allergic to egg, soy or both egg and soy and to compare those with the incidence of hypersensitivity reactions in children without allergy to egg and/or to soy. Those data were retrieved following longitudinal follow-up after the intervention. Allergy tests by skin and radioallergosorbent tests were performed in all children before the gastrointestinal endoscopy under anesthesia took place, but no results were known at the time of the sedation. A patient was defined as allergic to egg and/or soy if the patient had specific S-IgE level more than the normal level set by our institution (0.35 kU/L). The investigators would also investigate the influence of other obtained parameters in the dataset (age, ASA score, weight category, type of investigation, respiratory and neurological comorbidities, respiratory infections, GERD, other allergies) on those results with multivariate analysis. We considered that clinical features suggesting a hypersensitivity reaction present during anaesthesia were cutaneous, respiratory or cardiovascular manifestations. Depending on the severity of the reaction, necessitating prompt hemodynamic resuscitation with the administration of epinephrine, antihistamines, inhaled beta-agonists or corticosteroids.
Status | Completed |
Enrollment | 2299 |
Est. completion date | August 31, 2016 |
Est. primary completion date | August 31, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 16 Years |
Eligibility | Inclusion Criteria: - diagnostic gastrointestinal endoscopy - monitored anesthesia - received propofol during the procedure - allergic to egg and/or soy if the patient had specific S-IgE level more than the normal level set by our institution (0.35 kU/L) Exclusion Criteria: - Procedure without administration of propofol |
Country | Name | City | State |
---|---|---|---|
Belgium | UZ Brussel | Jette | Brussel |
Lead Sponsor | Collaborator |
---|---|
Universitair Ziekenhuis Brussel |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of participants with a hypersensitivity reaction | clinical features suggesting a hypersensitivity reaction present during anaesthesia were cutaneous, respiratory or cardiovascular manifestations. | minutes, during surgery | |
Secondary | Influence of gender on hypersensitivity reaction | See if there is a link or influence of gender on hypersensitivity reaction | minutes, during surgery | |
Secondary | Influence of ASA on hypersensitivity reaction | See if there is a link or influence of ASA on hypersensitivity reaction | minutes, during surgery | |
Secondary | Influence of type of procedure on hypersensitivity reaction | See if there is a link or influence of type of procedure on hypersensitivity reaction | minutes, during surgery | |
Secondary | Influence of age on hypersensitivity reaction | See if there is a link or influence of age on hypersensitivity reaction | minutes, during surgery | |
Secondary | Influence of weight on hypersensitivity reaction | See if there is a link or influence of weight on hypersensitivity reaction | minutes, during surgery | |
Secondary | Influence of height on hypersensitivity reaction | See if there is a link or influence of height on hypersensitivity reaction | minutes, during surgery | |
Secondary | Influence of the experience of the gastroenterologist on hypersensitivity reaction | See if there is a link or influence of experience of gastroenterologist on hypersensitivity reaction | minutes, during surgery | |
Secondary | Influence of a respiratory comorbitidity on hypersensitivity reaction | See if there is a link or influence of respiratory comorbidity on hypersensitivity reaction. | minutes, during surgery | |
Secondary | Influence of a neurological comorbidity on hypersensitivity reaction | See if there is a link or influence of a neurological comorbidity on hypersensitivity reaction | minutes, during surgery | |
Secondary | Influence of reason for investigation on hypersensitivity reaction | See if there is a link or influence of the reason for investigation on hypersensitivity reaction | minutes, during surgery | |
Secondary | Influence of a respiratory infection on hypersensitivity reaction | See if there is a link or influence of a respiratory infection on hypersensitivity reaction. | minutes, during surgery | |
Secondary | Influence of GERD on hypersensitivity reaction | See if there is a link or influence of GERD on hypersensitivity reaction | minutes, during surgery | |
Secondary | Influence of an allergy besides egg or soy on hypersensitivity reaction | See if there is a link or influence of another allergy besides egg or soy on hypersensitivity reaction. | minutes, during surgery | |
Secondary | Influence of ketamine on hypersensitivity reaction | See if there is a link or influence of ketamine on hypersensitivity reaction. | minutes, during surgery | |
Secondary | Influence of midazolam on hypersensitivity reaction | See if there is a link or influence of midazolam on hypersensitivity. | minutes, during surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04531540 -
Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test)
|
Phase 3 | |
Completed |
NCT00988065 -
Sugammadex Hypersensitivity Study (Study P06042)
|
Phase 1 | |
Completed |
NCT03563066 -
Effect of Benralizumab in Atopic Dermatitis
|
Phase 2 | |
Completed |
NCT02588326 -
Sensitivity of Pharmacokinetics to Differences in Particle Size Distribution of Suspension-based Nasal Sprays
|
Phase 1 | |
Completed |
NCT02916888 -
A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
|
N/A | |
Completed |
NCT02360072 -
Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma
|
||
Completed |
NCT02352168 -
Airway Inflammation in Children With Allergic Rhinitis and Intervention
|
N/A | |
Completed |
NCT01904604 -
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
|
Phase 2 | |
Completed |
NCT01494649 -
Pilot Study to Investigate the Efficacy of a Toothpaste in Providing Relief From Dentinal Hypersensitivity
|
N/A | |
Enrolling by invitation |
NCT05039229 -
Measures for Bioaerosol Reduction in the Salmon Industry
|
N/A | |
Enrolling by invitation |
NCT05675241 -
Characterizing the Inflammation Around Dental Implants
|
||
Completed |
NCT04006106 -
Defining ENDOtypes in Perioperative Hypersensitivity by Extensive Cellular and Molecular PHENotyping (ENDOPHEN)
|
||
Completed |
NCT04605471 -
A Study to Learn More About the Safety of Ultravist in Children and in the Elderly
|
||
Completed |
NCT03720470 -
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
|
Phase 3 | |
Terminated |
NCT05247567 -
Quaternary Ammonium and Immunization in Hairdressers
|
N/A | |
Completed |
NCT05119751 -
Vestibular Versus Sublingual Route of AIT Tablets
|
Phase 4 | |
Recruiting |
NCT06065137 -
Standardised Drug Provocation Testing in Perioperative Hypersensitivity
|
N/A | |
Active, not recruiting |
NCT05960266 -
Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study
|
Early Phase 1 | |
Not yet recruiting |
NCT04485299 -
Clinical Assessment of Bifluorid 10 vs Varnish Fluoride on The Exposed Hypersensitive Cervical Dentin in Adult Patient
|
Phase 2/Phase 3 | |
Completed |
NCT02686827 -
DBPC-Dose-finding-trial of Vitamin D3 for SCIT in Birch Pollen Allergic Patients.
|
Phase 2 |